Safety Questions Patients Should Ask First The main safety issue is not only whether retatrutide may cause side effects
It is unknown whether WEGOVY causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans as the human relevance of semaglutide-induced rodent thyroid C-cell tumors has not been determined
When we talk about microdosing GLP-1, were referring to doses substantially lower than whats typically prescribed for weight loss
However, patients with severe obesity, poorly controlled type 2 diabetes, or those who still need aggressive weight reduction often do better from staying on injectable therapy because it tends to be more powerful at higher doses
Overview BPC-157/TB-500 blend (20 mg) combines two research peptides frequently used in preclinical studies of tissue repair, vascular recruitment, and connective tissue remodeling